Receptor Tyrosine Kinases and Anticancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|9|1139-1149

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.9, 2005-04, pp. : 1139-1149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Targets for Anticancer Therapeutics

By  

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1773-1781

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutically Targeted Anticancer Agents: Inhibitors of Receptor Tyrosine Kinases

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 273-283

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

By  

Current Drug Targets, Vol. 17, Iss. 14, 2016-11 ,pp. : 1687-1703

Bentham Science Publishers

Access to resources Recommend Favorite